Australia, often regarded by market experts as the most mature clinical research market in Asia Pacific, has leveraged s...
Singapore: Pluristem Therapeutics, an Israel-based developer of placenta-based cell therapy products, has announced that...
Singapore: Quintiles has officially opened Greater China Regional Headquarters, further expanding its ability to help Ch...
Singapore: Ms Tanya Plibersek, federal Minister for Health, and Mr Greg Combet, Minister for Innovation and Industry, Au...
Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Indian Supreme Court on July 26 heard a Public Interest Litigation (PIL) seeking a ban on drug trials in ...
Singapore: Indian pharmaceutical company based in Bangalore, Jubilant Biosys has said that the US Food and Drug Administ...
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...
Predictions for the burden and impact of Chronic Obstructive Pulmonary Disease (COPD) have exceeded all expectations. In...
Singapore: BioPharmaceutical major Bristol-Myers Squibb (BMS) and Celgene have teamed up to conduct a combination clinic...
Singapore: "The regulatory pathway is in place, a compensation system is in place, and with the call for 'Make in India'...
In the past decade, clinical trials have become a controversial topic across the world despite the demonstrated effectiv...
Singapore: Quintiles has been recognized as one of the World's Best Multinational Workplaces by the Great Place to Work ...
Singapore: Novotech, Australia's largest Clinical Research Organization, has expanded its Asia business by opening a new...
Singapore: When we think "hybrid" we think of taking the best components from often opposing approaches and forming a ne...
Singapore: The new clinical trial data and New Global Health Economics and Outcomes Research (GHEOR) analyses assessing ...
Singapore: Parexel, a global clinical research organization with strong base in Asia, has acquired all outstanding equit...
